Reinterpretation of endothelial cell gaps induced by vasoactive mediators in guinea-pig, mouse and rat: many are transcellular pores

D Feng, J A Nagy, J Hipp, K Pyne, H F Dvorak, A M Dvorak, D Feng, J A Nagy, J Hipp, K Pyne, H F Dvorak, A M Dvorak

Abstract

1. In response to vascular permeabilizing agents, particulates circulating in the blood extravasate from venules through endothelial cell openings. These openings have been thought to be intercellular gaps though recently this view has been challenged. 2. To define the precise location of endothelial cell gaps, serial section electron microscopy and three-dimensional reconstructions were performed in skin and cremaster muscle of guinea-pigs, mice and rats injected locally with agents that enhance microvascular permeability: vascular permeability factor, histamine or serotonin. Ferritin and colloidal carbon were injected intravenously as soluble and particulate macromolecular tracers, respectively. 3. Both tracers extravasated from venules in response to all three permeability enhancing agents. The soluble plasma protein ferritin extravasated primarily by way of vesiculo-vacuolar organelles (VVOs), interconnected clusters of vesicles and vacuoles that traverse venular endothelium. In contrast, exogenous particulates (colloidal carbon) and endogenous particulates (erythrocytes, platelets) extravasated from plasma through transendothelial openings. 4. Serial electron microscopic sections and three-dimensional reconstructions demonstrated that eighty-nine of ninety-two openings were transendothelial pores, not intercellular gaps. Pore frequency increased 3- to 33-fold when carbon was used as tracer. 5. The results demonstrate that soluble and particulate tracers extravasate from venules by apparently different transcellular pathways in response to vasoactive mediators. However, some pores may derive from rearrangements of VVOs.

References

    1. Circ Res. 1967 Dec;21(6):833-47
    1. J Biophys Biochem Cytol. 1961 Dec;11:571-605
    1. Am J Pathol. 1974 Apr;75(1):171-80
    1. J Immunol. 1979 Jan;122(1):166-74
    1. Microvasc Res. 1980 Jan;19(1):108-26
    1. Science. 1983 Feb 25;219(4587):983-5
    1. J Invest Dermatol. 1986 May;86(5):577-81
    1. Am J Pathol. 1987 Jan;126(1):19-24
    1. J Physiol. 1988 Oct;404:1-29
    1. Prog Biophys Mol Biol. 1991;55(1):47-69
    1. J Physiol. 1990 Dec;431:379-401
    1. Lab Invest. 1992 Nov;67(5):596-607
    1. Cancer Metastasis Rev. 1993 Sep;12(3-4):303-24
    1. Physiol Rev. 1994 Jan;74(1):163-219
    1. Am J Pathol. 1995 May;146(5):1029-39
    1. J Cell Sci. 1995 Jun;108 ( Pt 6):2369-79
    1. Am J Physiol. 1995 Sep;269(3 Pt 1):L403-18
    1. J Physiol. 1995 Oct 15;488 ( Pt 2):427-37
    1. J Leukoc Biol. 1996 Jan;59(1):100-15
    1. J Exp Med. 1996 May 1;183(5):1981-6
    1. J Physiol. 1996 Apr 1;492 ( Pt 1):39-52
    1. Am J Physiol. 1997 Jan;272(1 Pt 1):L155-70
    1. Q J Exp Physiol Cogn Med Sci. 1959 Jan;44(1):51-66
    1. J Biophys Biochem Cytol. 1961 Dec;11:607-26
    1. J Cell Biol. 1969 Sep;42(3):647-72

Source: PubMed

3
Subscribe